Improving GERD medication adherence using the GERDCare smartphone app

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, open-label, randomized controlled trial that compares usual care with the addition of the GERDCare mobile application to support treatment adherence in adults with typical GERD symptoms. The app, developed with input from gastrointestinal experts, offers educational resources, symptom tracking, medication reminders, and direct patient–physician communication. Eligible participants are adults who own a smartphone and can use apps, and they are followed for four weeks after starting GERD treatment. Patients with acute GI emergencies, GI malignancy, severe chronic organ failure, pregnancy, significant alcohol abuse, or mental health issues affecting app use are excluded.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* ≥18 years old
* Presents with typical GERD symptoms (regurgitation, heartburn)
* Owns a smartphone and capable of using smartphone applications.

Exclusion Criteria:

* Acute GI conditions (upper GI bleeding, acute peptic ulcer…)
* GI malignancy (esophageal cancer, gastric cancer…)
* Severe chronic comorbidities (heart failure, liver failure, chronic kidney disease…)
* Pregnancy, alcohol abuse, mental health conditions impacting medication adherence or app usage

Where it's running

• Institute of Gastroenterology and Hepatology
  Hanoi, Vietnam Recruiting

Study contacts

• Study coordinator: Binh Phuc Nguyen, MD
• Email: binhnguyen.fsh@gmail.com
• Phone: +84356665787

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Quality sleep improvement with evening topical therapy for nocturnal GERD

  This trial tests a medical device given before bed to see if it reduces nighttime GERD symptoms and improves sleep and quality of life in adults with nocturnal reflux.

  Recruiting Cellmedis · Warsaw, Masovian Voivodeship and 1 other locations · NCT07700342

• Gerd symptoms with tegoprazan treatment in adults

  This study tests whether tegoprazan 50 mg (tablet or dispersible tablet) helps GERD symptoms and is safe in adults who meet criteria.

  Recruiting HK inno.N Corporation · Seoul · NCT07678177

• New topical treatment options for GERD symptoms

  This trial tests a medical device to see if it relieves GERD symptoms and improves quality of life in adults compared with a placebo.

  Recruiting Cellmedis · Warsaw, Masovian Voivodeship · NCT07624383

• Left-sided versus traditional bilateral laparoscopic repair for hiatal hernia with reflux

  This compares two laparoscopic operations—a left-sided approach and the traditional bilateral approach—to see which helps adults (18–85) with hiatal hernia whose reflux doesn't get better on usual acid‑reducing medicine.

  Recruiting Beijing Friendship Hospital · Beijing and 1 other locations · NCT07252115

• How three ice-cream formulations affect esophageal movement in people with GERD or weak esophageal motility

  This test will try three specially made ice creams to see if they change how the esophagus moves in people with ineffective esophageal motility or GERD.

  Recruiting Federal State Budgetary Scientific Institution · Moscow · NCT07121803

• Normal 24-hour esophageal pH‑impedance values in healthy Indian adults

  This project will measure 24-hour esophageal pH‑impedance readings, including acid exposure time, in healthy Indian adults to see what normal values are.

  Recruiting Asian Institute of Gastroenterology, India · Hyderabad, Telangana · NCT06928350

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.